Home

Investment Strategies for Biocapital

Tue, 12/04/2007 - 17:01 — Zangani
12/10/2007 - 12:00

Wrestling with Reimbursements: Who is going to pay for your biotech product or device technology?

Who's going to pay for the revolutionary drugs and devices you're funding? Your initial question is, of course, "Is the science there”? Once this was the most important question, but these days it's all about affordability to the payer and consumer - whether insurance companies will pay for it and how much of the cost will be transferred to the consumer.

Learning Objectives:

  • How will payer reform affect the financial success of your product?
  • At what point do you need to integrate reimbursement due diligence for your device or diagnostic?
  • How will reimbursement factors effect your investment evaluation and sales projections?

    Where:

    The Terrace Restaurant (located at main lobby entrance at the Georgia World Congress Center where ASH poster and exhibits are located)

    Register Here (Limited Registration Available)